188 related articles for article (PubMed ID: 7939077)
21. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
22. Complications of Lyme borreliosis.
Cooke WD; Dattwyler RJ
Annu Rev Med; 1992; 43():93-103. PubMed ID: 1580609
[TBL] [Abstract][Full Text] [Related]
23. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
24. [Recurrent erythema and fever].
Querol JM; Gómez A; Piera P
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):117-8. PubMed ID: 1643133
[No Abstract] [Full Text] [Related]
25. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
[TBL] [Abstract][Full Text] [Related]
26. [Multilocular erythema migrans in borreliosis].
Krischer S; Ott H; Barker M; Frank J; Erdmann S
Klin Padiatr; 2004; 216(4):236-7. PubMed ID: 15284948
[TBL] [Abstract][Full Text] [Related]
27. Current perspective on Lyme borreliosis.
Kaslow RA
JAMA; 1992 Mar; 267(10):1381-3. PubMed ID: 1740862
[No Abstract] [Full Text] [Related]
28. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
[TBL] [Abstract][Full Text] [Related]
29. Rocky Mountain "spotless" fever with an erythema migrans-like skin lesion.
Hughes C
Clin Infect Dis; 1995 Nov; 21(5):1328-9. PubMed ID: 8589170
[TBL] [Abstract][Full Text] [Related]
30. [Skin manifestations of Lyme borreliosis].
Nammous AH; Zubacki D; Dobrzycki I
Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
[TBL] [Abstract][Full Text] [Related]
31. Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosis.
Du W; Ma X; Nyman D; Povlsen K; Akguen N; Schneider EM
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):355-63. PubMed ID: 17888607
[TBL] [Abstract][Full Text] [Related]
32. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
[TBL] [Abstract][Full Text] [Related]
33. Lyme borreliosis: reliance on clinical rather than serologic diagnosis.
Delgrange E; Vanpee D; Garrino MG; Donckier J
Acta Clin Belg; 1998 Aug; 53(4):287-8. PubMed ID: 9795452
[No Abstract] [Full Text] [Related]
34. [Therapy indications in positive Borrelia titer].
Graninger W
Internist (Berl); 1999 Feb; 40(2):216. PubMed ID: 10097982
[No Abstract] [Full Text] [Related]
35. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.
Aguero-Rosenfeld ME; Nowakowski J; Bittker S; Cooper D; Nadelman RB; Wormser GP
J Clin Microbiol; 1996 Jan; 34(1):1-9. PubMed ID: 8748261
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Erythema migrans Borreliosis in blood donors.
Schmidt R; Gollmer E; Zunser R; Krüger J; Ackermann R
Infusionstherapie; 1989 Dec; 16(6):248-51. PubMed ID: 2625363
[TBL] [Abstract][Full Text] [Related]
37. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
[TBL] [Abstract][Full Text] [Related]
38. Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assay.
Rauer S; Wallich R; Neubert U
J Clin Microbiol; 2001 May; 39(5):2039-40. PubMed ID: 11388171
[No Abstract] [Full Text] [Related]
39. First case of documented Lyme borreliosis in the Alpes-Maritimes department of South-Eastern France: Erythema chronicum migrans associated with Borrelia afzelii.
Del Giudice P; Reverte M; Giraudon E; Durant J; Ahmed Abdoulah S; Jaulhac B; Poirier JP
Ann Dermatol Venereol; 2022 Jun; 149(2):146-147. PubMed ID: 35184901
[No Abstract] [Full Text] [Related]
40. Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum.
Jarefors S; Karlsson M; Forsberg P; Eliasson I; Ernerudh J; Ekerfelt C
Clin Exp Immunol; 2006 Feb; 143(2):322-8. PubMed ID: 16412057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
